Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial

Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new page revision v3.5.5 has been posted, superseding the previous v3.5.4. This reflects a minor update to the page content or formatting rather than any changes to study details.
    Difference
    0.0%
    Check dated 2026-06-05T10:35:07.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 was added for the Study Protocol document, replacing the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T05:39:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s displayed site/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor platform update rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:12.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page now reflects revision label v3.5.0 and the previous label v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:30:36.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:11:09.000Z thumbnail image

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.